PubRank

A Gaiger

Author PubWeight™ 20.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amplification of mitochondrial DNA in acute myeloid leukaemia. Br J Haematol 1996 2.17
2 Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006 1.70
3 Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Ann Oncol 2007 1.67
4 WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 2003 1.25
5 High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005 1.24
6 Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia 2005 1.12
7 Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 1992 1.09
8 High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004 1.09
9 Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma. Leukemia 2007 0.99
10 Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet 1993 0.93
11 Grey-scale and colour Doppler sonography in the evaluation of children with suspected bowel inflammation: correlation with colonoscopy and histological findings. Clin Radiol 2008 0.92
12 Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 1997 0.88
13 Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol 1999 0.88
14 Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab. Leukemia 2005 0.82
15 Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia 1995 0.81
16 Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia. Leukemia 2010 0.79
17 Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells. Ann Hematol 1993 0.79
18 Clinical study on the effect of infrared radiation of a tiled stove on patients with hand osteoarthritis. Scand J Rheumatol 2007 0.79
19 Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia. Cancer Res 1994 0.75
20 PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Br J Haematol 1995 0.75
21 [Problems of long-term therapy with anticoagulants]. Acta Med Austriaca 1992 0.75
22 Pure red cell aplasia in a case of Ph negative BCR/ABL rearranged CML with t(12;14)(q23;p11). Cancer Genet Cytogenet 1991 0.75
23 Immunophenotypic characterization of human bone marrow endosteal cells. Tissue Antigens 1999 0.75